Publication
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
John W. Eikelboom, Stuart J. Connolly, Jackie Bosch, Gilles R. Dagenais, Robert G. Hart, Olga Shestakovska, Rafael Diaz, Marco Alings, Eva M. Lonn, Sonia S. Anand, Petr Widimsky, Masatsugu Hori, Alvaro Avezum, Leopoldo S. Piegas, Kelley R.H. Branch, Jeffrey Probstfield, Deepak L. Bhatt, Jun Zhu, Yan Liang, Aldo P. Maggioni, Patricio Lopez-Jaramillo, Martin O’Donnell, Ajay K. Kakkar, Keith A.A. Fox, Alexander N. Parkhomenko, Georg Ertl, Stefan Störk, Matyas Keltai, Lars Ryden, Nana Pogosova, Antonio L. Dans, Fernando Lanas, Patrick J. Commerford, Christian Torp-Pedersen, Tomek J. Guzik, Peter B. Verhamme, Dragos Vinereanu, Jae-Hyung Kim, Andrew M. Tonkin, Basil S. Lewis, Camilo Felix, Khalid Yusoff, P. Gabriel Steg, Kaj P. Metsarinne, Nancy Cook Bruns, Frank Misselwitz, Edmond Chen, Darryl Leong, Salim Yusuf
New England Journal of Medicine, October 2017, New England Journal of Medicine (NEJM/MMS)
DOI: 10.1056/nejmoa1709118